Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections – Nature Nanotechnology
Source Node: 2548717
Time Stamp: Apr 17, 2024
Sepsis
Bosch and Randox to expand molecular diagnostics in $159m partnership
Source Node: 2544104
Time Stamp: Apr 12, 2024
Roche wins breakthrough designation for Tau biomarker test for Alzheimer’s
Source Node: 2541778
Time Stamp: Apr 11, 2024
FDA authorises Prenosis’ AI-based tool for sepsis diagnosis
Source Node: 2534864
Time Stamp: Apr 4, 2024
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients | BioSpace
Source Node: 2513519
Time Stamp: Mar 11, 2024
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
Source Node: 2495804
Time Stamp: Feb 24, 2024
SeaStar’s device granted humanitarian exemption approval for children with AKI
Source Node: 2494080
Time Stamp: Feb 23, 2024
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury | BioSpace
Source Node: 2492745
Time Stamp: Feb 21, 2024
Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent – Nature Nanotechnology
Source Node: 2484153
Time Stamp: Feb 16, 2024
Full-length single-molecule protein fingerprinting – Nature Nanotechnology
Source Node: 2481342
Time Stamp: Feb 13, 2024
Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases – Nature Nanotechnology
Source Node: 2461827
Time Stamp: Jan 29, 2024
SeaStar Medical builds enrolment in pivotal trial for AKI device
Source Node: 2420026
Time Stamp: Dec 29, 2023
SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury | BioSpace
Source Node: 2418642
Time Stamp: Dec 27, 2023
Inflammatix receives Breakthrough Device Designation for TriVerity system
Source Node: 2403050
Time Stamp: Nov 29, 2023
ABIONYX Pharma presents preclinical results for CER-001 in Brain Fog, at the 1st International Scientific Congress on Brain-Kidney Interaction in Naples on November 23-24, 2023
Source Node: 2396736
Time Stamp: Nov 23, 2023
Nanotechnology Now – Press Release: Silver nanoparticles: guaranteeing antimicrobial safe-tea
Source Node: 2393457
Time Stamp: Nov 22, 2023
Green tea-silver nanoparticles: A promising weapon against superbugs
Source Node: 2393490
Time Stamp: Nov 17, 2023
The Week’s 10 Biggest Funding Rounds: Divergent Technologies And Biotech Rule
Source Node: 2388096
Time Stamp: Nov 17, 2023
Meet five medical companies that have received 2023 business awards from the Institute of Physics – Physics World
Source Node: 2356984
Time Stamp: Oct 30, 2023